The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.
Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.
Pune-based vaccine manufacturer SII has already received cell and vector samples for the production of Sputnik V from Russia's Gamaleya Center, the developer of the vaccine.
Russia's RDIF has also reached agreements with other pharmaceutical companies in India including Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma & Virchow Biotech.
Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 250 million vials of Sputnik V in India. It has already received nearly 3 million doses.
The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.
Recommendations appear in Niti Aayog’s Tax Policy Working Paper Series–II. It says there is a need to shift away from fear-based enforcement to trust-based governance.
In service with the British military since 2019, it is also known as the Martlet missile. Ukrainians have also deployed these missiles against Russian troops.
Education, reservations, govt jobs are meant to bring equality and dignity. That we are a long way from that is evident in the shoe thrown at the CJI and the suicide of Haryana IPS officer. The film Homebound has a lesson too.
COMMENTS